medigraphic.com

2001, Number S1

<< Back Next >>

Arch Cardiol Mex 2001; 71 (S1)

Myocardial Viability. Stunned and hibernating myocardium. Usefulness of the myocardium scintigraphy

Bialostozky D

Language: Spanish
References: 36
Page: 25-31
PDF size: 53.96 Kb.


ABSTRACT

The diagnosis of viability in the presence of heart failure in coronary artery disease has acquired great importance due to its excellent therapeutic results. Due to its frequency it has become a public health problem. The characteristics of stunned and hibernating myocardium and the protocols to study perfusion, contractile reserve and metabolic activity are described, with emphasis in the Thalium and Tc99m-sestambi studies.


REFERENCES

  1. HO KKI, PINSKY JL, KANNEL WB, LEVY D: The epidemiology of heart failure, the Framingham study. J Am Coll Cardiol 1993; 22: 6A-13A.

  2. MARWICK TH: The viable myocardium- epidemiology, detection, and clinical implications. Lancet 1998; 351: 815-19.

  3. TILLISH J, BRUNKEN R, MARSHALL R, ET AL: Reveribilirty of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986; 314: 884-88.

  4. BRUNKEN R, TILLIS J, SCHWAIGER M, ET AL: Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence of viable tissue in some infract regions by positron emission tomography. Circulation 1986; 173: 951-63.

  5. BRAUNWALD E, KIONER RA: The stunned myocardium: prolonged postischemic ventricular dysfunction. Circulation 1982; 166: 1146-9.

  6. RAHIMTOOLA SH: A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985; 72(Suppl V): 123-135.

  7. BIALOSTOZKY D: Contribuciones de la medicina nuclear a los problemas de la cardiología. Arch Inst Cardiol Mex 1991; 61: 513-15.

  8. KLONER RA, BOFFL R, MARBAN E, ET AL: Medical and cellular implications of stunning, hybernation and preconditioning. A NHLBI workshop. Circulation 1998; 97: 1848-67.

  9. SCHWARZ ER, SCHOENDUBE FA, KOSTIN S, ET AL: Prolonged myocardial hibernation exacerbates cardiomyocytes degeneration and impaires recovery of function after revascularization. J Am Coll Cardiol 1998; 134: 1018-26.

  10. TOPOL EJ, WEISS JL, GUZMAN PA ET AL: Immediate improvement of dysfunctional myocardial segments after coronary revascularization: detection by intraoperative transesophageal echocardiography. J Am Coll Cardiol 1984; 4: 1123-34.

  11. BRAUNWALD E, RUTHERFORD JD: Reversible ischemic left ventricular dysfunction: evidence for the “hibernating myocardium”. J Am Coll Cardiol 1986; 8: 11467-70.

  12. PICCOLO E, DE MICHELI A, GARCIA PEREIRA D, COCCO F, SODI PALLARES D: L’évolution électrocardiographic des signes de nócrose au cours de I’infarctus du myocarde. Mal Cardiovasc 1960; 1(4): 503-34.

  13. MARGONATO A, CHIERCHIA SIL, XUEREB RG, ET AL: Specificity and sensitivity of exercise-indu-ced ST segment elevation for detection of residual viability: comparison with fluorodeoxyglucose and positron emission tomography. J Am Coll Cardiol 1995; 25: 11032-8.

  14. ROZANSKI A, BERMAN DS, GRAY R, ET AL: Use of thallium-102 redistribution scintigraphy in the preoperative differentiation of reversible and nonreversible myocardial asynergy. Circulation 1981; 64: 936-44.

  15. DILSIZIAN V: Myocardial Viability. A Clinical and Scientific Treatise. Futura Publishing Co Inc. Armonk NY 2000. Section 2, pg 461.

  16. BANKA VS, BODENHEIMER MM, HEFFANT RH: Determinants, of reversible asynergy. The native coronary circulation. Circulation 1975; 52: 810-16.

  17. DEWOOD MA, SPORES J, NOTSKE R, ET AL: Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: 897-902.

  18. DILSIZÁN V, ROCCO, TP, STRAUSS HW, ET AL: Technetium-99m isonitrile myocardial uptake at rest. 1: relation to severity of coronary stenosis. J Am Coll Cardiol 1989; 14: 3112-118 (1673-77).

  19. BIALOSTOZKY D: El Miocardio Aturdido e Hibernante. Importancia de la Cardiología Nuclear en su Detección. Diagnóstico de la Cardiopatía Isquémica. Un Enfoque Multidisciplinado. Editor Jesús Vargas Barrón. Editorial Médica Panamericana. México DF. 1999. pgs. 204-12.

  20. BIALOSTOZKY D, LECHUGA A, ALEXANDERSON E, ET AL: Viabilidad miocárdica. Arch Inst Cardiol Mex 1995; 65: 293-99.

  21. DILSIZIAN V, BONOW RO: Current diagnostic techniques of assessing myocardial viability in patients with hybernating and stunned myocardium. Circulation 1993; 187: 1-20.

  22. POHOST GM: Cardiovascular applications of magnetic resonance. Mount Kisco NY. American Heart Association. Futura Publishing Company. 1st Ed. 1993.

  23. KELLY MJ: Fluorina 18-labeled fluorodeoxyglucose myocardial scintigraphy with Anger gamma camera for assessing myocardial viability. J Nucl Cardiol 1995; 2: 360-5.

  24. TAMAKI N, KAWARNOTO M, TAKAHASHI N, ET AL: Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thahum imaging. J Am Coll Cardiol 1992; 22: 1621-7.

  25. WASHEK J, HINKLE G, BASMADJIAN G, ET AL: Effect of cardiac drugs on imaging studies with thallous chioride TI-201. Am J Hosp Pharm 1981; 38: 1726-8.

  26. DILSIZIAN V, ROCCO TP, FREEDMAN NM, ET AL: Enhanced detection of ischernic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Eng J Med 1990; 323: 141-45.

  27. DILSIZIAN V, ARRIGHI JA, CIODATI JG, ET AL: Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thakkium reinjection and [18F] Fluorodeoxyglucose. Circulation 1994; 189: 578-87.

  28. SAWADA SG, ALIMAN KC, MUZIK O, ET AL: Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol 1994; 123: 92-8.

  29. UDDELSON JE, COLEMAN PS, METHERALL JA, ET AL: Predicting recovery of severe regional ventricular dysfunction- comparison of resting scintigraphy with201 TI and99mTc-sestamibi. Circulation 1994; 189: 2552-61.

  30. GERMANO G, KIAT H, KABANAGH PB, MORIEL M, MAZZANTI M, SU H-T, ET AL. Automatic qualification of ejection fraction from gated myocardial perfusion Spect. J Nucl Med 1995, 36: 2138-2147.

  31. BERMAN DA, KIAT H, FRIEDMAN JD, ET AL: Separate acquisition rest thallium-201 /stress Tc-99m sestamibi dual isotope myocardial perfusion single photon emission computer tomography (SPECT). J Nucl Cardiol 1994; 35: 81-8.

  32. BISL G, SCÍAGRA R, SANTORO GM, FAZZINI PF: Rest-Technetium-99m sestamibi in combination with short-term administration of nitrates, feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994; 124: 1282-9.

  33. SIAGRÁ R, BISI G, SANTORO GM, AGNOLUCCI M, ZOCCARATO O, FAZZINI PF: Influence of the assessment of defect severity and intravenous nitrate administration during tracer injection on the detection of viable hibernating myocardium with data-base quantitative technetium 99m-labeled sestamibi single-photon emission computed tomography. J Nucl Cardiol 1999; 3: 221-30.

  34. BATISTA JF, PEREZTOL O, VALDÉS JA, ET AL: Improved detection of myocardial perfusion reversibility by rest-nitroglycerine Tc 99mMBI: comparison with Tj1-201 reinjection. J Nucl Cardiol 1999; 6: 480-6.

  35. RAGOSTA M, BELLER GA,WATSON DD, ET AL: Quantitative planar rest-redistribution thallium imaging detection of myocardial viability and prediction of improvement in left vetricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993; 87: 1630-41.

  36. SIEBELINK HMJ, BLANKSMA P, CRIJNS HJG, BAX JJ, ET AL: No difference in cardiac event-free survival between positron emission tomography- guided and single-photon emission computed tomography-guided patient management. J Am Coll Cardiol 2001; 137: 81-8.




2020     |     www.medigraphic.com